Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation via JAK2/STAT3 Pathway Inhibition
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation via JAK2/STAT3 Pathway Inhibition
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-07-22
DOI
10.3389/fimmu.2021.714943
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tibetan medicine Ershiwuwei Lvxue Pill attenuates collagen-induced arthritis via inhibition of JAK2/STAT3 signaling pathway
- (2021) Chuan Liu et al. JOURNAL OF ETHNOPHARMACOLOGY
- Inflammation-Mediated Angiogenesis in Ischemic Stroke
- (2021) Hua Zhu et al. Frontiers in Cellular Neuroscience
- The bidirectional role of the JAK2/STAT3 signaling pathway and related mechanisms in cerebral ischemia-reperfusion injury
- (2021) Yi Zhong et al. EXPERIMENTAL NEUROLOGY
- LPS‐induced inflammation desensitizes hepatocytes to Fas‐induced apoptosis through Stat3 activation—The effect can be reversed by ruxolitinib
- (2020) Antonio Markotic et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Microglial IRF5-IRF4 regulatory axis regulates neuroinflammation after cerebral ischemia and impacts stroke outcomes
- (2020) Abdullah Al Mamun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Muscone relieves inflammatory pain by inhibiting microglial activation-mediated inflammatory response via abrogation of the NOX4/JAK2-STAT3 pathway and NLRP3 inflammasome
- (2020) Shanshan Yu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine “storm” and risk factor for damage of hematopoietic stem cells
- (2020) Mariusz Z. Ratajczak et al. LEUKEMIA
- The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19
- (2020) Bakiye Goker Bagca et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation
- (2020) F. La Rosée et al. LEUKEMIA
- Severe COVID-19: NLRP3 Inflammasome Dysregulated
- (2020) Daan F. van den Berg et al. Frontiers in Immunology
- Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper
- (2020) Sonu Bhaskar et al. Frontiers in Immunology
- A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre-Clinical Discoveries
- (2020) Danilo Fiore et al. Cancers
- Blood substitution therapy rescues the brain of mice from ischemic damage
- (2020) Xuefang Ren et al. Nature Communications
- The NLRP3 inflammasome drives inflammation in ischemia/reperfusion injury after transient middle cerebral artery occlusion in mice
- (2020) Maximilian Franke et al. BRAIN BEHAVIOR AND IMMUNITY
- Pre-hematopoietic cell transplant Ruxolitinib in patients with primary and secondary myelofibrosis
- (2019) Rachel B. Salit et al. BONE MARROW TRANSPLANTATION
- Extent of Ischemic Brain Injury After Thrombotic Stroke Is Independent of the NLRP3 (NACHT, LRR and PYD Domains-Containing Protein 3) Inflammasome
- (2019) Eloise Lemarchand et al. STROKE
- Atractylenolide III ameliorates cerebral ischemic injury and neuroinflammation associated with inhibiting JAK2/STAT3/Drp1-dependent mitochondrial fission in microglia
- (2019) Kecheng Zhou et al. PHYTOMEDICINE
- Sexually dimorphic microglia and ischemic stroke
- (2019) Nadine Kerr et al. CNS Neuroscience & Therapeutics
- Ischaemic stroke
- (2019) Bruce C. V. Campbell et al. Nature Reviews Disease Primers
- Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of Ruxolitinib
- (2019) Elena Maria Elli et al. Frontiers in Oncology
- Meisoindigo Protects Against Focal Cerebral Ischemia-Reperfusion Injury by Inhibiting NLRP3 Inflammasome Activation and Regulating Microglia/Macrophage Polarization via TLR4/NF-κB Signaling Pathway
- (2019) Yingze Ye et al. Frontiers in Cellular Neuroscience
- Upregulation of NLRP3 via STAT3-dependent histone acetylation contributes to painful neuropathy induced by bortezomib
- (2018) Cui-Cui Liu et al. EXPERIMENTAL NEUROLOGY
- Upregulation of miR-216a exerts neuroprotective effects against ischemic injury through negatively regulating JAK2/STAT3-involved apoptosis and inflammatory pathways
- (2018) Yu Shuang Tian et al. JOURNAL OF NEUROSURGERY
- Ras-Related C3 Botulinum Toxin Substrate 1 Promotes Axonal Regeneration after Stroke in Mice
- (2018) Lin Liu et al. Translational Stroke Research
- “Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
- (2018) Emira Bousoik et al. Frontiers in Oncology
- Inflammation and myeloproliferative neoplasms
- (2017) Federico Lussana et al. JOURNAL OF AUTOIMMUNITY
- Homocysteine exaggerates microglia activation and neuroinflammation through microglia localized STAT3 overactivation following ischemic stroke
- (2017) Shuang Chen et al. Journal of Neuroinflammation
- Inhibition of cerebral ischemia/reperfusion injury-induced apoptosis: nicotiflorin and JAK2/STAT3 pathway
- (2017) Guang-qiang Hu et al. Neural Regeneration Research
- ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin)
- (2017) Alla Guekht et al. STROKE
- Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis
- (2016) R. Das et al. BLOOD
- Glycyrrhizin protects against focal cerebral ischemia via inhibition of T cell activity and HMGB1-mediated mechanisms
- (2016) Xiaoxing Xiong et al. Journal of Neuroinflammation
- Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases
- (2016) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera
- (2015) Alessandro M. Vannucchi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Leptin receptor expressing neurons express phosphodiesterase-3B (PDE3B) and leptin induces STAT3 activation in PDE3B neurons in the mouse hypothalamus
- (2015) Maitrayee Sahu et al. PEPTIDES
- IL-4 Is Required for Sex Differences in Vulnerability to Focal Ischemia in Mice
- (2015) Xiaoxing Xiong et al. STROKE
- Remission of Recalcitrant Dermatomyositis Treated with Ruxolitinib
- (2014) Thorsten Hornung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biology and significance of the JAK/STAT signalling pathways
- (2012) Hiu Kiu et al. GROWTH FACTORS
- Interleukin-6, a Major Cytokine in the Central Nervous System
- (2012) María Erta et al. International Journal of Biological Sciences
- Inflammatory Cytokines in Experimental and Human Stroke
- (2012) Kate Lykke Lambertsen et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Distinctive Effects of T Cell Subsets in Neuronal Injury Induced by Cocultured Splenocytes In Vitro and by In Vivo Stroke in Mice
- (2012) Lijuan Gu et al. STROKE
- Lentivirus-mediated shRNA interference targeting STAT3 inhibits human pancreatic cancer cell invasion
- (2009) Guang Yang et al. WORLD JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started